![]() |
Enron Mail |
All,
I have looked over the U.S. credit GTC and the long descriptions. I see we have decided to go with quarterly billing, rather than monthly. Will the payment/collections cycle cause any heartburn for the back office? I didn't spot any problems with the long descriptions. A few relatively minor comments on the GTC's - which you may or may not want to consider: - Clause 2.(e) (i) (1) - Does this clause preclude us from doing business with banks or other financial institutions? Could we append: "with regard to the Transaction"? - What happens if a Rep or Warranty is broken? Does that constitute sufficient breach to terminate the contract? I'm thinking specifically about sleeving, which is perhaps covered by Clause 2(e)(ii)(1)? I still think that sleeving is one of the most significant commercial risks faced by online trading of derivatives. If I were working for a third party, I'd immediately look for ways to set up a sleeving service to sell credit protection to the Reference Entities where the Reference Entity or its affiliate views its own risk differently from Enron. If I were the Reference Entity in question, I'd consider: a) Buying a load of protection via sleeving and then declaring bankruptcy - then do a Phoenix (in the UK at least) b) Buy a load of protection via sleeving, then take the Credit Derivatives to another third party financial institution and using the credit derivatives as collateral to increase my line of credit - I'm no expert, but I suspect there might be an interesting leverage effect here, which might actually cause a significant increase in Enron's risk exposure. c) Like (b), only the financial institution could buy the credit derivative with or without the need for sleeving - we probably need a restriction on this? (I know financial institutions are not our preferred counterparts up front, but if I were a financial insitution, I'd quickly find a way around this limitation - Affiliates or Sleevers. - Do you think it would beneficial to strengthen our protection against sleeving by adding something to Clause 2, like: "It is not entering into a Transaction for the purpose of concluding a similar transaction with the party (or any Affiliate of such party) which is the Reference Entity in the Transaction". - Should Def'n of "Contract Currency" be "Contractual Currency"? ("Contractual" is also used in the Long Descriptions) - Def'n of "Credit Product" - after "Entity", should we insert "which is"? - Are we being a bit too nasty by defining the Determination Agent as "Enron"? As the reference to Determination Agent in the contract is in a context similar to that of an arbitrator, it seems a bit cheeky to then define ourselves as the arbitrator - would this be enforceable if we were in court? I'm assuming the other GTC's are very similar to the U.S. one and I have not read them. Dave
|